期刊
IMMUNOTHERAPY
卷 12, 期 17, 页码 1209-1212出版社
FUTURE MEDICINE LTD
DOI: 10.2217/imt-2020-0244
关键词
circulating tumor cells; immune checkpoint inhibitors; immunotherapy; neoadjuvant; urothelial bladder carcinoma